Type 3 hypersensitivity is an immune reaction in which antibodies bind to foreign substances (antigens) floating in the bloodstream, forming clumps called immune complexes. These complexes then settle into tissues and trigger inflammation that damages the surrounding area. Unlike an immediate allergic reaction (type 1), which happens within minutes, type 3 reactions develop over hours to days and can affect organs far from where the original antigen entered the body.
How the Reaction Unfolds
The process follows three distinct steps: formation, deposition, and inflammation. After you’re exposed to an antigen, whether it’s a drug, an infectious organism, or even one of your own proteins, your immune system produces antibodies against it within about 7 to 10 days. Those antibodies latch onto the antigen while it’s still dissolved in the blood, creating small circulating immune complexes.
Normally, cleanup cells called macrophages grab these complexes and dispose of them. The problem starts when there’s an excess of antigen. The resulting complexes are small enough to slip past macrophages but too numerous for the cleanup system to handle. They accumulate in the bloodstream and eventually lodge in tissues where blood is filtered or flows slowly: the kidneys (specifically the tiny filtering units called glomeruli), the lining of joints, blood vessel walls, and the air sacs of the lungs.
Once stuck in tissue, the complexes activate a chain of defensive proteins known as the complement system. This generates chemical signals that make nearby blood vessels leakier and call in white blood cells, particularly neutrophils. Those neutrophils arrive expecting to destroy an invader, but instead they release destructive enzymes and toxic oxygen molecules directly into the surrounding tissue. At the same time, platelets clump together and form tiny blood clots. The combined effect is inflammation, tissue damage, and in severe cases, loss of blood flow to the affected area.
Local vs. Systemic Reactions
Type 3 hypersensitivity can be either localized to one spot or spread throughout the body, and the distinction matters because the symptoms look very different.
The Arthus Reaction (Local)
The Arthus reaction is the classic example of a localized type 3 response. It happens when an antigen is injected into the skin of someone who already has high levels of antibodies against it, most often after repeated vaccinations. The antigen diffuses into nearby blood vessel walls, where it meets antibodies and forms immune complexes right at the injection site. Symptoms typically begin 2 to 12 hours after exposure and include pain, swelling, firmness, and redness around the injection area. In mild cases, the affected zone is less than 5 centimeters across. In more severe cases, redness and swelling can spread across an entire upper arm from shoulder to elbow. Most Arthus reactions resolve within a week without lasting effects, though rare severe episodes can cause skin ulceration or tissue death at the site.
Serum Sickness (Systemic)
Serum sickness is the systemic counterpart. Instead of complexes forming in one spot, they circulate throughout the body and deposit in multiple organs at once. The classic triad of symptoms is fever, skin rash, and joint pain or swelling affecting several joints. Modern triggers include certain biologic medications used for autoimmune conditions, anti-venom treatments, and some vaccinations such as the rabies vaccine. The name dates back to an era when patients were injected with horse-derived serum to treat infections, but the underlying mechanism is identical regardless of the trigger.
Where Immune Complexes Settle
The organs most vulnerable to immune complex damage are those that filter blood or have extensive small blood vessel networks. The kidneys are a prime target because glomeruli act as fine-mesh filters. Circulating complexes tend to get trapped in the spaces between filtering cells and along the inner lining of the capillary walls. The glomerular basement membrane, a thin structural layer within the filter, blocks larger complexes from passing through, which means they pile up on one side and provoke inflammation there. This is why kidney inflammation (glomerulonephritis) is one of the hallmark complications of type 3 hypersensitivity.
Joints are another common site. The synovial membrane that lines joint capsules has a rich blood supply and a tendency to trap immune complexes, leading to swelling and pain that can mimic arthritis. Blood vessel walls themselves are also vulnerable, particularly in the skin, where complex deposition can cause a type of small-vessel inflammation that shows up as a purplish rash on the legs and feet. The lungs can be affected too, especially when the inhaled antigen meets antibodies in the alveolar walls.
Conditions Linked to Type 3 Hypersensitivity
Several well-known diseases involve type 3 mechanisms, either as the primary driver or as a major contributor to organ damage:
- Lupus (SLE): The body produces antibodies against its own DNA and other nuclear proteins. The resulting immune complexes deposit widely, causing kidney disease, joint inflammation, skin rashes, and blood vessel damage.
- Post-streptococcal glomerulonephritis: After a strep throat infection, immune complexes containing strep antigens lodge in the kidneys, causing inflammation that leads to blood in the urine, swelling, and high blood pressure.
- Hypersensitivity pneumonitis (farmer’s lung): Repeated inhalation of mold spores or other organic dust leads to immune complex formation in the lungs, causing cough, breathlessness, and eventually scarring if exposure continues.
- Polyarteritis nodosa: Immune complexes, sometimes linked to hepatitis B infection, deposit in medium-sized artery walls and cause widespread vessel inflammation affecting the skin, nerves, kidneys, and gut.
- Serum sickness: A systemic reaction to foreign proteins introduced by medications or animal-derived treatments, as described above.
How It Differs From Other Hypersensitivity Types
The Gell and Coombs classification divides hypersensitivity into four types, and the differences are practical. Type 1 is the classic allergy: mast cells release histamine within minutes of encountering an allergen, producing hives, wheezing, or anaphylaxis. Type 2 involves antibodies targeting cells or tissues directly, as happens when the immune system attacks red blood cells during a transfusion reaction. Type 4 is a delayed response driven by T cells rather than antibodies, taking 48 to 72 hours to develop, as seen in poison ivy rashes or tuberculin skin tests.
Type 3 sits in between. It depends on antibodies like types 1 and 2, but the damage comes not from direct cell targeting but from immune complexes depositing in tissues. The timeline is intermediate as well: slower than type 1 (hours to days rather than minutes) but generally faster than type 4. The key distinguishing feature is that tissue injury occurs wherever complexes happen to settle, which means symptoms can appear in organs that had no direct contact with the original antigen.
Diagnosis and Management
Identifying a type 3 reaction involves blood tests that look for indirect evidence of immune complex activity. Because the complement system gets heavily consumed during the inflammatory cascade, blood levels of complement proteins (C3 and C4) typically drop during an active flare. Elevated markers of general inflammation, along with low complement and detectable circulating immune complexes, point toward this type of reaction. In kidney disease, a tissue biopsy can reveal the characteristic pattern of immune complex deposits along the glomerular membrane.
Treatment centers on two goals: removing the triggering antigen when possible, and controlling the inflammatory damage. If a medication is responsible, stopping it is the most important step, and symptoms like those of serum sickness generally resolve on their own once the trigger is gone. For autoimmune conditions like lupus, where the body’s own proteins are the antigen, long-term immune suppression is typically needed to reduce antibody production and prevent ongoing complex formation. Anti-inflammatory medications help manage symptoms during active flares, and the specific treatment approach depends heavily on which organs are involved and how severe the damage is.